Japan Society of Hepatology guidelines for sarcopenia in liver disease (1st edition): Recommendation from the working group for creation of sarcopenia assessment criteria
Sarcopenia is defined by muscle loss and muscle dysfunction. Sarcopenia is classified into primary and secondary types, based on the cause. Primary sarcopenia is mainly aging‐related sarcopenia, whereas secondary sarcopenia is the reduced muscle mass and strength that accompanies an underlying disea...
Saved in:
| Published in | Hepatology research Vol. 46; no. 10; pp. 951 - 963 |
|---|---|
| Main Authors | , , , , , |
| Format | Journal Article |
| Language | English |
| Published |
Netherlands
Blackwell Publishing Ltd
01.09.2016
|
| Subjects | |
| Online Access | Get full text |
Cover
Loading…
| Abstract | Sarcopenia is defined by muscle loss and muscle dysfunction. Sarcopenia is classified into primary and secondary types, based on the cause. Primary sarcopenia is mainly aging‐related sarcopenia, whereas secondary sarcopenia is the reduced muscle mass and strength that accompanies an underlying disease. Given the essential role of the liver in metabolism, secondary sarcopenia due to nutritional disorders or other factors can frequently occur in liver disease. In 2015, the Japan Society of Hepatology (JSH) decided to establish its own assessment criteria for sarcopenia in liver disease because the number of liver disease patients with sarcopenia is expected to increase and there is cumulative evidence to indicate sarcopenic patients have poor clinical outcomes. A working group to create assessment criteria for sarcopenia has thus been established by the JSH. In this article, we summarize the current knowledge with regard to sarcopenia and present the assessment criteria for sarcopenia in liver disease proposed by the JSH (1st edition). To the best of our knowledge, this is globally the first proposed assessment criteria for sarcopenia specializing in liver disease. |
|---|---|
| AbstractList | Sarcopenia is defined by muscle loss and muscle dysfunction. Sarcopenia is classified into primary and secondary types, based on the cause. Primary sarcopenia is mainly aging‐related sarcopenia, whereas secondary sarcopenia is the reduced muscle mass and strength that accompanies an underlying disease. Given the essential role of the liver in metabolism, secondary sarcopenia due to nutritional disorders or other factors can frequently occur in liver disease. In 2015, the Japan Society of Hepatology (JSH) decided to establish its own assessment criteria for sarcopenia in liver disease because the number of liver disease patients with sarcopenia is expected to increase and there is cumulative evidence to indicate sarcopenic patients have poor clinical outcomes. A working group to create assessment criteria for sarcopenia has thus been established by the JSH. In this article, we summarize the current knowledge with regard to sarcopenia and present the assessment criteria for sarcopenia in liver disease proposed by the JSH (1st edition). To the best of our knowledge, this is globally the first proposed assessment criteria for sarcopenia specializing in liver disease. Sarcopenia is defined by muscle loss and muscle dysfunction. Sarcopenia is classified into primary and secondary types, based on the cause. Primary sarcopenia is mainly aging-related sarcopenia, whereas secondary sarcopenia is the reduced muscle mass and strength that accompanies an underlying disease. Given the essential role of the liver in metabolism, secondary sarcopenia due to nutritional disorders or other factors can frequently occur in liver disease. In 2015, the Japan Society of Hepatology (JSH) decided to establish its own assessment criteria for sarcopenia in liver disease because the number of liver disease patients with sarcopenia is expected to increase and there is cumulative evidence to indicate sarcopenic patients have poor clinical outcomes. A working group to create assessment criteria for sarcopenia has thus been established by the JSH. In this article, we summarize the current knowledge with regard to sarcopenia and present the assessment criteria for sarcopenia in liver disease proposed by the JSH (1st edition). To the best of our knowledge, this is globally the first proposed assessment criteria for sarcopenia specializing in liver disease.Sarcopenia is defined by muscle loss and muscle dysfunction. Sarcopenia is classified into primary and secondary types, based on the cause. Primary sarcopenia is mainly aging-related sarcopenia, whereas secondary sarcopenia is the reduced muscle mass and strength that accompanies an underlying disease. Given the essential role of the liver in metabolism, secondary sarcopenia due to nutritional disorders or other factors can frequently occur in liver disease. In 2015, the Japan Society of Hepatology (JSH) decided to establish its own assessment criteria for sarcopenia in liver disease because the number of liver disease patients with sarcopenia is expected to increase and there is cumulative evidence to indicate sarcopenic patients have poor clinical outcomes. A working group to create assessment criteria for sarcopenia has thus been established by the JSH. In this article, we summarize the current knowledge with regard to sarcopenia and present the assessment criteria for sarcopenia in liver disease proposed by the JSH (1st edition). To the best of our knowledge, this is globally the first proposed assessment criteria for sarcopenia specializing in liver disease. |
| Author | Shiraki, Makoto Hiramatsu, Akira Hino, Keisuke Nishiguchi, Shuhei Moriya, Kyoji Nishikawa, Hiroki |
| Author_xml | – sequence: 1 givenname: Hiroki surname: Nishikawa fullname: Nishikawa, Hiroki organization: Division of Hepatobiliary and Pancreatic Disease, Department of Internal Medicine, Hyogo College of Medicine, Hyogo, Japan – sequence: 2 givenname: Makoto surname: Shiraki fullname: Shiraki, Makoto organization: Department of Gastroenterology and Internal Medicine, Gifu University Graduate School of Medicine, Gifu, Japan – sequence: 3 givenname: Akira surname: Hiramatsu fullname: Hiramatsu, Akira organization: Department of Gastroenterology and Metabolism, Applied Life Science, Institute of Biomedical and Health Science, Hiroshima University, Hiroshima, Japan – sequence: 4 givenname: Kyoji surname: Moriya fullname: Moriya, Kyoji organization: Department of Infection Control and Prevention, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan – sequence: 5 givenname: Keisuke surname: Hino fullname: Hino, Keisuke organization: Department of Hepatology and Pancreatology, Kawasaki Medical School, Okayama, Japan – sequence: 6 givenname: Shuhei surname: Nishiguchi fullname: Nishiguchi, Shuhei email: nishiguc@hyo-med.ac.jp organization: Division of Hepatobiliary and Pancreatic Disease, Department of Internal Medicine, Hyogo College of Medicine, Hyogo, Japan |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/27481650$$D View this record in MEDLINE/PubMed |
| BookMark | eNp9kctu1DAUhi1URC-w4QGQl6VSim-JM-xQVTqgUlAphZ3lOCdT08QOtqdlXomnxDNpK4QQ3tiyvu8_0n920ZbzDhB6TskhzefVFYzhkDIpxSO0Q2vJCsLFt6385nVVVFxU22g3xu-EUEmYeIK2mRQ1rUqyg36916N2-LM3FtIK-w7PYdTJ936xwoulbaG3DiLufMBRB-NHcFZj63BvbyDg1kbQEfA-jQlDa5P17uVrfA7GDwO4Vq8_cBf8gNMV4Fsfrq1b4EXwy3ETagJMTB79xwAdI8SYE1ImbIJg9VP0uNN9hGd39x768vb44mhenH48eXf05rQwopSimNWmJHymhS6pZrosu6ZkLVRc1iVtKyk6QTltpWTA6rZuWG4CWmgaMFXFOPA9tD_ljsH_WEJMarDRQN9rB34ZFc1CXQk6oxl9cYcumwFaNQY76LBS9_1m4GACTPAxBugeEErUenlqvTy1WV6GyV-wsWlTTgra9v9W6KTc2h5W_wlX8-NP5_dOMTk2Jvj54OhwrSrJZam-np2oi0tBPpzNLxXnvwHw-r7W |
| CitedBy_id | crossref_primary_10_1111_hepr_13253 crossref_primary_10_1111_hepr_13492 crossref_primary_10_1186_s12891_019_2983_4 crossref_primary_10_3390_nu15224816 crossref_primary_10_1186_s12893_022_01896_2 crossref_primary_10_1002_rco2_20 crossref_primary_10_1111_hepr_13499 crossref_primary_10_1002_jgh3_12582 crossref_primary_10_1080_17474124_2020_1757427 crossref_primary_10_1111_ijcp_14863 crossref_primary_10_1007_s10147_021_01958_0 crossref_primary_10_1111_hepr_13000 crossref_primary_10_1111_hepr_13485 crossref_primary_10_3390_jcm8101647 crossref_primary_10_3390_nu15194190 crossref_primary_10_3390_jcm9010166 crossref_primary_10_1016_j_jgo_2024_101817 crossref_primary_10_1111_jgh_16590 crossref_primary_10_2490_jjrmc_19001 crossref_primary_10_1016_j_ctarc_2024_100829 crossref_primary_10_1038_s41598_024_57342_1 crossref_primary_10_3390_cancers12082146 crossref_primary_10_1007_s00535_024_02124_9 crossref_primary_10_1111_hepr_13244 crossref_primary_10_3390_jcm9040936 crossref_primary_10_1111_apt_15571 crossref_primary_10_1007_s00268_019_05145_1 crossref_primary_10_3389_fendo_2023_1101892 crossref_primary_10_3390_life11050399 crossref_primary_10_1016_j_hpb_2021_08_947 crossref_primary_10_1080_07853890_2022_2081872 crossref_primary_10_1111_jgh_14058 crossref_primary_10_1016_j_clnesp_2020_05_025 crossref_primary_10_1111_ases_13374 crossref_primary_10_14309_ctg_0000000000000584 crossref_primary_10_3390_cancers16193356 crossref_primary_10_1002_jgh3_70124 crossref_primary_10_62347_UJVP4361 crossref_primary_10_3390_diagnostics10060433 crossref_primary_10_1245_s10434_023_13569_2 crossref_primary_10_3892_mco_2017_1321 crossref_primary_10_1016_j_nut_2020_111081 crossref_primary_10_1111_jgh_15377 crossref_primary_10_3390_jcm9103239 crossref_primary_10_1002_jcsm_12869 crossref_primary_10_3390_nu12113474 crossref_primary_10_1007_s11604_022_01283_0 crossref_primary_10_1111_hepr_13589 crossref_primary_10_1111_hepr_13469 crossref_primary_10_1186_s43066_023_00265_9 crossref_primary_10_7717_peerj_16652 crossref_primary_10_1002_jgh3_12588 crossref_primary_10_1111_ggi_13311 crossref_primary_10_3390_app10165403 crossref_primary_10_3390_nu10091185 crossref_primary_10_1186_s12876_023_02835_y crossref_primary_10_3390_life10080137 crossref_primary_10_1111_jgh_14277 crossref_primary_10_1186_s12876_024_03438_x crossref_primary_10_3389_fimmu_2024_1396927 crossref_primary_10_1097_MD_0000000000007377 crossref_primary_10_1111_hepr_13051 crossref_primary_10_3390_biomedicines10112806 crossref_primary_10_1002_jcsm_12853 crossref_primary_10_3390_jcm11072012 crossref_primary_10_3390_ijms26031043 crossref_primary_10_1111_hepr_14027 crossref_primary_10_3390_jcm9010095 crossref_primary_10_2152_jmi_70_80 crossref_primary_10_1111_ctr_13786 crossref_primary_10_3390_diagnostics14192191 crossref_primary_10_3390_ijms25020964 crossref_primary_10_1186_s12876_022_02236_7 crossref_primary_10_1038_s41598_025_91787_2 crossref_primary_10_3390_jcm12237483 crossref_primary_10_1590_1806_9282_20221606 crossref_primary_10_3390_diagnostics13132218 crossref_primary_10_1016_j_diabres_2018_02_025 crossref_primary_10_1016_j_aanat_2023_152104 crossref_primary_10_3390_jcm7120553 crossref_primary_10_1016_j_acra_2022_10_025 crossref_primary_10_1159_000504604 crossref_primary_10_2342_ymj_70_157 crossref_primary_10_15747_ACNM_2021_13_2_62 crossref_primary_10_2169_naika_111_50 crossref_primary_10_1038_s41598_025_87458_x crossref_primary_10_1016_j_aohep_2024_101585 crossref_primary_10_1080_01635581_2022_2049322 crossref_primary_10_1038_s41419_020_03353_5 crossref_primary_10_3390_life11090899 crossref_primary_10_1007_s10147_024_02539_7 crossref_primary_10_1097_SLE_0000000000001075 crossref_primary_10_3390_jcm8122057 crossref_primary_10_1080_17474124_2021_1829470 crossref_primary_10_1007_s00520_023_07845_w crossref_primary_10_2169_internalmedicine_3787_24 crossref_primary_10_1186_s12880_025_01600_9 crossref_primary_10_3390_jcm11082079 crossref_primary_10_1371_journal_pone_0270786 crossref_primary_10_1111_apt_17978 crossref_primary_10_3390_nu15224724 crossref_primary_10_3390_cancers16020442 crossref_primary_10_3390_jcm10071419 crossref_primary_10_1007_s10147_021_01927_7 crossref_primary_10_20960_nh_05585 crossref_primary_10_1016_j_nut_2022_111777 crossref_primary_10_1016_j_mcna_2022_12_007 crossref_primary_10_1038_s41598_023_50574_7 crossref_primary_10_1016_j_nut_2021_111475 crossref_primary_10_3390_nu12010186 crossref_primary_10_3892_wasj_2021_87 crossref_primary_10_1038_s41598_024_70266_0 crossref_primary_10_3389_fonc_2022_974116 crossref_primary_10_2169_internalmedicine_4456_24 crossref_primary_10_1016_j_clnesp_2021_01_045 crossref_primary_10_3390_app11041882 crossref_primary_10_3390_ijms22041917 crossref_primary_10_1002_poh2_94 crossref_primary_10_1002_ags3_12671 crossref_primary_10_1002_jgh3_12976 crossref_primary_10_1016_j_pan_2024_01_002 crossref_primary_10_1007_s11356_023_26926_1 crossref_primary_10_3390_nu13072415 crossref_primary_10_1016_j_jfma_2021_09_020 crossref_primary_10_1111_1759_7714_15313 crossref_primary_10_1016_j_afos_2022_04_001 crossref_primary_10_1093_jjco_hyab116 crossref_primary_10_5946_ce_2022_278 crossref_primary_10_1007_s12664_022_01295_8 crossref_primary_10_1111_hepr_14051 crossref_primary_10_3390_jcm8010016 crossref_primary_10_3390_nu9060595 crossref_primary_10_1111_hepr_14179 crossref_primary_10_1002_rco2_96 crossref_primary_10_1016_j_exger_2019_110801 crossref_primary_10_1007_s12011_021_02675_5 crossref_primary_10_3390_ph14010036 crossref_primary_10_4254_wjh_v14_i7_1480 crossref_primary_10_1002_jcsm_13334 crossref_primary_10_1002_jcsm_13212 crossref_primary_10_1136_bcr_2021_247129 crossref_primary_10_1371_journal_pone_0218136 crossref_primary_10_1111_hepr_13192 crossref_primary_10_1186_s12876_020_01501_x crossref_primary_10_1245_s10434_021_09658_9 crossref_primary_10_4235_agmr_18_0046 crossref_primary_10_3390_cancers15174223 crossref_primary_10_1038_s41598_022_07810_3 crossref_primary_10_1007_s10388_022_00925_6 crossref_primary_10_1016_j_jhep_2022_01_010 crossref_primary_10_1007_s00408_022_00536_z crossref_primary_10_1002_jpen_2222 crossref_primary_10_3390_cancers12071795 crossref_primary_10_1507_endocrj_EJ19_0478 crossref_primary_10_3390_healthcare9081021 crossref_primary_10_1016_j_nut_2020_110957 crossref_primary_10_13105_wjma_v10_i3_81 crossref_primary_10_1016_j_jceh_2022_12_002 crossref_primary_10_3390_nu13061874 crossref_primary_10_3390_jcm8091359 crossref_primary_10_1371_journal_pone_0257672 crossref_primary_10_3390_jcm8091485 crossref_primary_10_1007_s00535_022_01923_2 crossref_primary_10_3390_nu15040891 crossref_primary_10_1097_MOG_0000000000000922 crossref_primary_10_3390_nu15153335 crossref_primary_10_1007_s00535_017_1378_2 crossref_primary_10_17987_jcsm_cr_v3i2_66 crossref_primary_10_3390_jcm9010255 crossref_primary_10_1007_s00261_024_04439_w crossref_primary_10_1016_j_jamda_2021_05_011 crossref_primary_10_3390_geriatrics9020035 crossref_primary_10_1016_j_gastha_2021_11_009 crossref_primary_10_1186_s13063_024_08373_6 crossref_primary_10_3390_cancers11081206 crossref_primary_10_1038_s41598_021_92087_1 crossref_primary_10_3164_jcbn_21_61 crossref_primary_10_3390_cancers13020194 crossref_primary_10_1186_s40001_022_00760_6 crossref_primary_10_1371_journal_pone_0198812 crossref_primary_10_1002_jgh3_12777 crossref_primary_10_1002_jcsm_12212 crossref_primary_10_1111_jgh_14820 crossref_primary_10_5217_ir_2023_00035 crossref_primary_10_1002_j_2617_1619_2018_tb00009_x crossref_primary_10_3390_ijms21165678 crossref_primary_10_1016_j_jceh_2023_101318 crossref_primary_10_3390_cancers14010010 crossref_primary_10_3390_jcm9092974 crossref_primary_10_1002_jhbp_455 crossref_primary_10_1111_liv_15693 crossref_primary_10_1002_hep4_2005 crossref_primary_10_1007_s10989_021_10163_6 crossref_primary_10_1080_01635581_2023_2176199 crossref_primary_10_3390_jcm11030508 crossref_primary_10_1186_s43166_024_00289_y crossref_primary_10_1186_s12877_023_04485_x crossref_primary_10_1111_hepr_14087 crossref_primary_10_1093_jjco_hyaa218 crossref_primary_10_1111_hepr_14084 crossref_primary_10_1007_s00595_024_02970_3 crossref_primary_10_1016_j_heliyon_2024_e25824 crossref_primary_10_1002_rco2_40 crossref_primary_10_1007_s00268_020_05857_9 crossref_primary_10_1007_s00423_023_03170_2 crossref_primary_10_1097_MD_0000000000021061 crossref_primary_10_3164_jcbn_19_85 crossref_primary_10_1038_s41430_020_0638_z crossref_primary_10_1007_s10147_023_02466_z crossref_primary_10_1097_BRS_0000000000005018 crossref_primary_10_1080_01635581_2024_2314317 crossref_primary_10_1002_jcsm_12797 crossref_primary_10_1002_jpen_2386 crossref_primary_10_1007_s11914_024_00899_7 crossref_primary_10_3389_fnut_2022_1033831 crossref_primary_10_3390_life11040349 crossref_primary_10_1097_CM9_0000000000002937 crossref_primary_10_3390_nu10081072 crossref_primary_10_1017_S0007114521000106 crossref_primary_10_1007_s00464_020_08099_x crossref_primary_10_3390_jcm10184099 crossref_primary_10_1016_j_biopha_2020_111181 crossref_primary_10_1016_j_clinre_2024_102379 crossref_primary_10_1097_MPA_0000000000001985 crossref_primary_10_1016_j_arr_2024_102460 crossref_primary_10_2169_internalmedicine_0900_22 crossref_primary_10_3390_ijtm2030027 crossref_primary_10_2958_suizo_35_166 crossref_primary_10_1038_s41598_023_28528_w crossref_primary_10_1097_MEG_0000000000002459 crossref_primary_10_3390_nu9101135 crossref_primary_10_1002_cam4_5810 crossref_primary_10_1111_hepr_12843 crossref_primary_10_3390_nu9060620 crossref_primary_10_1007_s00535_018_1485_8 crossref_primary_10_1111_jgh_16806 crossref_primary_10_3390_jcm13195925 crossref_primary_10_1002_poh2_10 crossref_primary_10_1093_ibd_izaa306 crossref_primary_10_3389_fnut_2023_1272728 crossref_primary_10_3390_nu14224855 crossref_primary_10_1097_MEG_0000000000002346 crossref_primary_10_3390_medicina56070319 crossref_primary_10_1080_19932820_2023_2204564 crossref_primary_10_1007_s00464_022_09595_y crossref_primary_10_1038_s41598_022_10514_3 crossref_primary_10_3390_jcm10153448 crossref_primary_10_3389_fnut_2024_1434630 crossref_primary_10_1002_ags3_12716 crossref_primary_10_1097_MD_0000000000027212 crossref_primary_10_3390_jcm10184080 crossref_primary_10_1177_1756284820971197 crossref_primary_10_1002_jhbp_1164 crossref_primary_10_3390_nu13103519 crossref_primary_10_1097_MEG_0000000000001368 crossref_primary_10_2957_kanzo_61_715 crossref_primary_10_1093_postmj_qgad097 crossref_primary_10_1111_hepr_13911 crossref_primary_10_1186_s12885_021_08905_2 crossref_primary_10_1111_hepr_13906 crossref_primary_10_1111_hepr_13904 crossref_primary_10_1111_1751_2980_13329 crossref_primary_10_1007_s00262_020_02794_3 crossref_primary_10_1016_j_cld_2023_01_005 crossref_primary_10_1016_j_jhepr_2024_101113 crossref_primary_10_1097_MEG_0000000000001472 crossref_primary_10_1007_s00535_021_01821_z crossref_primary_10_1055_a_2338_1144 crossref_primary_10_1007_s00774_023_01488_x crossref_primary_10_1159_000487858 crossref_primary_10_3390_life10050076 crossref_primary_10_3748_wjg_v28_i14_1430 crossref_primary_10_1097_MD_0000000000028680 crossref_primary_10_2147_JHC_S444530 crossref_primary_10_1002_jgh3_12900 crossref_primary_10_1097_MEG_0000000000002435 crossref_primary_10_1371_journal_pone_0299313 crossref_primary_10_1111_joor_12948 crossref_primary_10_14814_phy2_15917 crossref_primary_10_1007_s12072_022_10363_2 crossref_primary_10_3390_jcm8060782 crossref_primary_10_3390_cancers13092247 crossref_primary_10_1002_cnr2_2084 crossref_primary_10_1097_MEG_0000000000002536 crossref_primary_10_1097_SLA_0000000000002555 crossref_primary_10_3390_cancers13164105 crossref_primary_10_1111_hepr_13731 crossref_primary_10_3390_nu13124428 crossref_primary_10_3892_mmr_2021_12494 crossref_primary_10_1016_j_archger_2021_104430 crossref_primary_10_1016_j_cgh_2020_08_066 crossref_primary_10_3390_nu16162653 crossref_primary_10_1002_poh2_50 crossref_primary_10_1002_hep4_1207 crossref_primary_10_1111_hepr_12999 crossref_primary_10_1016_j_pan_2023_02_002 crossref_primary_10_1002_jcsm_13268 crossref_primary_10_1016_j_spinee_2022_05_013 crossref_primary_10_3390_nu12123810 crossref_primary_10_3390_cancers17020209 crossref_primary_10_1038_s41598_022_27238_z crossref_primary_10_3748_wjg_v30_i12_1727 crossref_primary_10_1155_2020_3576974 crossref_primary_10_1002_jhbp_970 crossref_primary_10_1080_17474124_2021_1848542 crossref_primary_10_1159_000530991 crossref_primary_10_3892_br_2023_1690 crossref_primary_10_1002_ags3_12875 crossref_primary_10_1002_hep4_1309 crossref_primary_10_1016_j_ejso_2024_108403 crossref_primary_10_1111_hepr_12873 crossref_primary_10_3390_jcm11030582 crossref_primary_10_1016_j_nut_2018_03_011 crossref_primary_10_1136_bmjgast_2017_000194 crossref_primary_10_1002_lt_25777 crossref_primary_10_3390_ijms21155357 crossref_primary_10_2957_kanzo_63_305 crossref_primary_10_1111_hepr_13959 crossref_primary_10_1136_bmjgast_2017_000190 crossref_primary_10_3390_nu16223847 crossref_primary_10_1111_jgh_14538 crossref_primary_10_1097_MEG_0000000000002532 crossref_primary_10_3390_nu9101054 crossref_primary_10_1016_j_clnesp_2025_02_004 crossref_primary_10_1111_hepr_13834 crossref_primary_10_1002_ags3_12845 crossref_primary_10_3390_jcm8050634 crossref_primary_10_3390_medicina59122099 crossref_primary_10_3390_nu16244422 crossref_primary_10_3390_metabo11040242 crossref_primary_10_1002_jcsm_12392 crossref_primary_10_1002_jpen_1696 crossref_primary_10_1177_17562848221142417 crossref_primary_10_3389_fmed_2021_739251 crossref_primary_10_1002_jcsm_12276 crossref_primary_10_1097_MEG_0000000000001791 crossref_primary_10_2957_kanzo_62_525 crossref_primary_10_3389_fnut_2024_1375994 crossref_primary_10_1097_MEG_0000000000001415 crossref_primary_10_3892_br_2020_1273 crossref_primary_10_1007_s12072_024_10708_z crossref_primary_10_1111_hepr_13820 crossref_primary_10_1007_s10620_022_07806_z crossref_primary_10_3389_fsurg_2022_852137 crossref_primary_10_3390_diagnostics10040238 crossref_primary_10_3389_fonc_2020_01581 crossref_primary_10_1111_hepr_13816 crossref_primary_10_1111_hepr_13934 crossref_primary_10_1002_jgh3_12702 crossref_primary_10_1097_MD_0000000000006868 crossref_primary_10_2739_kurumemedj_MS6723009 crossref_primary_10_3390_ijms21155254 crossref_primary_10_3389_fnut_2022_978110 crossref_primary_10_3389_fimmu_2025_1557839 crossref_primary_10_1016_j_pan_2021_03_002 crossref_primary_10_1038_s41430_022_01215_1 crossref_primary_10_1016_j_jceh_2024_101347 crossref_primary_10_1111_hepr_13897 crossref_primary_10_1038_s41598_024_66766_8 crossref_primary_10_3390_ijms22031425 crossref_primary_10_3390_nu12071915 crossref_primary_10_1016_j_nut_2024_112440 crossref_primary_10_1111_hepr_13405 crossref_primary_10_1111_hepr_13765 crossref_primary_10_1007_s12020_019_02162_x crossref_primary_10_1002_ohn_655 crossref_primary_10_3390_life11080740 crossref_primary_10_1111_hepr_13639 crossref_primary_10_4174_astr_2023_105_4_219 crossref_primary_10_3390_cancers12030559 crossref_primary_10_1016_j_transproceed_2017_09_017 crossref_primary_10_1371_journal_pone_0262675 crossref_primary_10_1007_s00535_019_01623_4 crossref_primary_10_11638_jssmn_55_5_201 crossref_primary_10_1186_s12957_022_02627_w crossref_primary_10_34172_mejdd_2024_376 crossref_primary_10_1002_kjm2_12622 crossref_primary_10_1038_s41598_020_67147_7 crossref_primary_10_11569_wcjd_v29_i20_1167 crossref_primary_10_1159_000536267 crossref_primary_10_3390_nu15051123 crossref_primary_10_1016_j_nut_2020_111007 crossref_primary_10_1093_jjco_hyad097 crossref_primary_10_3390_diagnostics13071245 crossref_primary_10_1007_s00268_020_05828_0 crossref_primary_10_1111_jgh_14449 crossref_primary_10_3390_ijms24087517 crossref_primary_10_1016_j_heliyon_2024_e35354 crossref_primary_10_1016_j_clnesp_2021_01_008 crossref_primary_10_3892_ijmm_2022_5157 crossref_primary_10_1038_s41598_023_31065_1 crossref_primary_10_1111_tri_13690 crossref_primary_10_1007_s00535_021_01788_x crossref_primary_10_2196_60683 crossref_primary_10_1007_s00520_023_07659_w crossref_primary_10_1111_hepr_13622 crossref_primary_10_1002_jcsm_12906 crossref_primary_10_1038_s41598_020_67847_0 crossref_primary_10_1111_hepr_13981 crossref_primary_10_1002_jmri_28690 crossref_primary_10_1016_j_suronc_2024_102043 crossref_primary_10_3390_jcm10184214 crossref_primary_10_1016_j_jceh_2023_03_012 crossref_primary_10_3390_diagnostics11071262 crossref_primary_10_1111_hepr_13331 crossref_primary_10_1186_s12937_024_01037_w crossref_primary_10_1111_hepr_13698 crossref_primary_10_3390_jcm8030336 crossref_primary_10_1111_hepr_13453 crossref_primary_10_7759_cureus_64360 crossref_primary_10_3390_nu14091864 crossref_primary_10_3390_life11020086 crossref_primary_10_2490_jjrmc_58_1120 crossref_primary_10_1016_j_igie_2024_06_006 crossref_primary_10_1097_MEG_0000000000000986 crossref_primary_10_3390_cancers13194842 crossref_primary_10_4009_jsdt_53_235 crossref_primary_10_3350_cmh_2022_0231 crossref_primary_10_3892_mco_2022_2542 crossref_primary_10_3390_ijms22168491 crossref_primary_10_1111_hepr_13321 crossref_primary_10_1111_hepr_13322 crossref_primary_10_1111_ctr_13495 crossref_primary_10_1111_apt_17671 crossref_primary_10_1038_s41598_021_96203_z crossref_primary_10_1038_s41575_024_00974_5 crossref_primary_10_3390_jcm9082381 crossref_primary_10_1007_s00280_020_04105_0 crossref_primary_10_1007_s00535_020_01711_w crossref_primary_10_1111_apt_16581 crossref_primary_10_1111_jgh_14133 crossref_primary_10_3390_jcm12103351 crossref_primary_10_1111_hepr_13679 crossref_primary_10_1097_MD_0000000000008761 crossref_primary_10_1111_hepr_13678 crossref_primary_10_1038_s41598_020_70585_y crossref_primary_10_3389_fonc_2022_1039987 crossref_primary_10_3390_jcm10245966 crossref_primary_10_1111_hepr_13308 crossref_primary_10_3177_jnsv_64_445 crossref_primary_10_3389_fnut_2024_1398690 crossref_primary_10_1186_s12893_024_02395_2 crossref_primary_10_1097_MEG_0000000000000968 crossref_primary_10_1016_j_bbadis_2023_166770 crossref_primary_10_3390_nu15183878 crossref_primary_10_3390_hematolrep16010012 crossref_primary_10_1002_hep4_1604 crossref_primary_10_1016_j_nut_2022_111807 crossref_primary_10_1111_hepr_13667 crossref_primary_10_1111_hepr_13420 crossref_primary_10_3390_jcm9051570 crossref_primary_10_2490_jjrmc_55_410 crossref_primary_10_1038_s41598_020_73176_z crossref_primary_10_3390_diagnostics13111959 crossref_primary_10_4236_ojgas_2018_86022 crossref_primary_10_1186_s12885_018_4673_2 |
| Cites_doi | 10.1007/s00726-015-2067-1 10.1111/hepr.12085 10.1210/endo.142.9.8365 10.1002/lt.23970 10.1111/hepr.12616 10.1038/nm.3918 10.1152/ajpendo.00488.2005 10.5535/arm.2015.39.2.155 10.1002/lt.23811 10.1016/j.jocd.2015.04.012 10.1111/ajt.12221 10.1007/s10147-015-0898-0 10.1002/lt.23495 10.1097/MCG.0000000000000208 10.1111/hepr.12004 10.1111/j.1365-2265.2012.04347.x 10.1002/bjs.9258 10.1111/ggi.12210 10.1038/ctg.2015.31 10.1016/j.jamda.2013.11.025 10.1038/387083a0 10.1016/S1542-3565(05)00017-0 10.1111/apt.13549 10.1016/j.mam.2016.02.002 10.1016/j.clnu.2008.01.001 10.1152/ajpendo.00186.2004 10.1016/j.jamda.2011.01.003 10.1016/j.nut.2016.04.003 10.1016/j.bbrc.2003.07.016 10.1007/s00535-014-0964-9 10.1152/jappl.2000.89.1.81 10.1016/j.nut.2014.07.005 10.1111/hepr.12217 10.1097/MD.0000000000002442 10.1097/00003086-200210001-00017 10.1111/hepr.12674 10.7150/jca.11212 10.1007/s13539-012-0069-3 10.1016/j.amjsurg.2012.07.035 10.1016/j.cgh.2013.08.050 10.1111/hepr.12194 10.1093/ageing/afq034 10.1016/S0168-8278(01)00130-1 10.1111/apt.13156 10.1002/hep.25950 10.3748/wjg.v20.i23.7286 10.1073/pnas.1317049110 10.1007/s00535-015-1068-x 10.1016/j.jhep.2014.02.026 10.1093/ageing/afu115 10.1111/hepr.12562 10.1016/S1665-2681(19)30874-9 10.1016/j.jhep.2015.02.031 10.1093/ajcn/50.5.1231 10.1213/ANE.0b013e3181eac1c9 10.1016/j.cgh.2011.08.028 10.1245/s10434-014-3686-6 10.1002/lt.23724 10.1016/0016-5085(92)91122-K |
| ContentType | Journal Article |
| Copyright | 2016 The Japan Society of Hepatology 2016 The Japan Society of Hepatology. |
| Copyright_xml | – notice: 2016 The Japan Society of Hepatology – notice: 2016 The Japan Society of Hepatology. |
| DBID | BSCLL AAYXX CITATION NPM 7X8 |
| DOI | 10.1111/hepr.12774 |
| DatabaseName | Istex CrossRef PubMed MEDLINE - Academic |
| DatabaseTitle | CrossRef PubMed MEDLINE - Academic |
| DatabaseTitleList | CrossRef PubMed MEDLINE - Academic |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine |
| EISSN | 1872-034X |
| EndPage | 963 |
| ExternalDocumentID | 27481650 10_1111_hepr_12774 HEPR12774 ark_67375_WNG_TV40MNHV_3 |
| Genre | article Journal Article |
| GroupedDBID | --- --K .3N .GA .Y3 05W 0R~ 10A 1B1 1OC 1~5 29I 31~ 33P 3SF 4.4 4G. 50Y 50Z 51W 51X 52M 52N 52O 52P 52R 52S 52T 52U 52V 52W 52X 53G 5GY 5HH 5LA 5VS 66C 7-5 702 7PT 8-0 8-1 8-3 8-4 8-5 8UM 930 A01 A03 AAEDT AAESR AAEVG AAHHS AALRI AANLZ AAONW AAQFI AAQXK AASGY AAXRX AAXUO AAZKR ABCQN ABCUV ABDBF ABEML ABIJN ABJNI ABPVW ABQWH ABXGK ACAHQ ACBWZ ACCFJ ACCZN ACGFO ACGFS ACGOF ACIUM ACMXC ACPOU ACPRK ACSCC ACXBN ACXQS ADBBV ADBTR ADEOM ADIZJ ADKYN ADMGS ADMUD ADOZA ADXAS ADZMN ADZOD AEEZP AEGXH AEIGN AEIMD AENEX AEQDE AEUQT AEUYR AFBPY AFFPM AFGKR AFPWT AFZJQ AHBTC AIACR AIAGR AITUG AITYG AIURR AIWBW AJBDE ALAGY ALMA_UNASSIGNED_HOLDINGS ALUQN AMBMR AMYDB ASPBG ATUGU AVWKF AZBYB AZFZN AZVAB BAFTC BDRZF BFHJK BHBCM BMXJE BROTX BRXPI BSCLL BY8 C45 CAG COF CS3 D-6 D-7 D-E D-F DCZOG DPXWK DR2 DRFUL DRMAN DRSTM DU5 EBD EBS EJD ESX EX3 F00 F01 F04 F5P FDB FEDTE FGOYB FUBAC G-Q G-S G.N GODZA H.X HF~ HGLYW HVGLF HZ~ IHE IX1 J0M K48 KBYEO LATKE LC2 LC3 LEEKS LH4 LITHE LOXES LP6 LP7 LUTES LW6 LYRES M41 MEWTI MK4 MRFUL MRMAN MRSTM MSFUL MSMAN MSSTM MXFUL MXMAN MXSTM N04 N05 N9A NF~ NQ- O66 O9- OIG OVD P2P P2W P2X P2Z P4B P4D Q.N Q11 QB0 R.K R2- RIG ROL RPZ RX1 SEW SSZ SUPJJ TEORI TUS UB1 UHS V8K W8V W99 WBKPD WHWMO WIH WIJ WIK WOHZO WOW WQJ WRC WVDHM WXI WXSBR XG1 ZZTAW ~IA ~WT AAHQN AAIPD AAMNL AANHP AAYCA ABWVN ACRPL ACUHS ACYXJ ADNMO AFWVQ ALVPJ AAYXX ACVFH ADCNI AEUPX AEYWJ AFPUW AGHNM AGQPQ AGYGG AIGII CITATION NPM 7X8 AAMMB AEFGJ AGXDD AIDQK AIDYY |
| ID | FETCH-LOGICAL-c4574-98c5039a4a51a2a55fb52de637851d674f4131d772e28d8b2816edebbec6623e3 |
| IEDL.DBID | DR2 |
| ISSN | 1386-6346 |
| IngestDate | Thu Jul 10 22:21:31 EDT 2025 Wed Feb 19 01:59:42 EST 2025 Tue Jul 01 01:58:17 EDT 2025 Thu Apr 24 23:03:27 EDT 2025 Wed Jan 22 16:40:10 EST 2025 Wed Oct 30 09:52:26 EDT 2024 |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 10 |
| Keywords | assessment criteria liver disease mechanism prognosis sarcopenia |
| Language | English |
| License | http://onlinelibrary.wiley.com/termsAndConditions#vor 2016 The Japan Society of Hepatology. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c4574-98c5039a4a51a2a55fb52de637851d674f4131d772e28d8b2816edebbec6623e3 |
| Notes | istex:8781CDEC64563837AE976EFC4CEEE8677F0AA9EB ark:/67375/WNG-TV40MNHV-3 ArticleID:HEPR12774 ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
| PMID | 27481650 |
| PQID | 1816864191 |
| PQPubID | 23479 |
| PageCount | 13 |
| ParticipantIDs | proquest_miscellaneous_1816864191 pubmed_primary_27481650 crossref_primary_10_1111_hepr_12774 crossref_citationtrail_10_1111_hepr_12774 wiley_primary_10_1111_hepr_12774_HEPR12774 istex_primary_ark_67375_WNG_TV40MNHV_3 |
| ProviderPackageCode | CITATION AAYXX |
| PublicationCentury | 2000 |
| PublicationDate | 2016-09 September 2016 2016-09-00 2016-Sep 20160901 |
| PublicationDateYYYYMMDD | 2016-09-01 |
| PublicationDate_xml | – month: 09 year: 2016 text: 2016-09 |
| PublicationDecade | 2010 |
| PublicationPlace | Netherlands |
| PublicationPlace_xml | – name: Netherlands |
| PublicationTitle | Hepatology research |
| PublicationTitleAlternate | Hepatol Res |
| PublicationYear | 2016 |
| Publisher | Blackwell Publishing Ltd |
| Publisher_xml | – name: Blackwell Publishing Ltd |
| References | Kawaguchi T, Shiraishi K, Ito T et al. Branched-chain amino acids prevent hepatocarcinogenesis and prolong survival of patients with cirrhosis. Clin Gastroenterol Hepatol 2014; 12: 1012-18. McPherron AC, Lawler AM, Lee SJ. Regulation of skeletal muscle mass in mice by a new TGF-beta superfamily member. Nature 1997; 387: 83-90. Hayashi F, Matsumoto Y, Momoki C et al. Physical inactivity and insufficient dietary intake are associated with the frequency of sarcopenia in patients with compensated viral liver cirrhosis. Hepatol Res 2013; 43: 1264-75. Santilli V, Bernetti A, Mangone M, Paoloni M. Clinical definition of sarcopenia. Clin Cases Miner Bone Metab 2014; 11: 177-80. Masuda T, Shirabe K, Ikegami T et al. Sarcopenia is a prognostic factor in living donor liver transplantation. Liver Transpl 2014; 20: 401-7. DiMartini A, Cruz RJ Jr, Dew MA et al. Muscle mass predicts outcomes following liver transplantation. Liver Transpl 2013; 19: 1172-80. Cruz-Jentoft AJ, Baeyens JP, Bauer JM et al. Sarcopenia: European consensus on definition and diagnosis. Age Ageing 2010; 39: 412-23. Kaibori M, Ishizaki M, Matsui K et al. Perioperative exercise for chronic liver injury patients with hepatocellular carcinoma undergoing hepatectomy. Am J Surg 2013; 206: 202-9. Cruz-Jentoft AJ, Landi F, Schneider SM et al. Prevalence of and interventions for sarcopenia in ageing adults: a systematic review. Report of the International Sarcopenia Initiative (EWGSOP and IWGS). Age Ageing 2014; 43: 748-59. Iwasa M, Hara N, Terasaka E et al. Evaluation and prognosis of sarcopenia using impedance analysis in patients with liver cirrhosis. Hepatol Res 2014; 44: E316-17. Hanai T, Shiraki M, Nishimura K et al. Sarcopenia impairs prognosis of patients with liver cirrhosis. Nutrition 2015; 31: 193-9. Blau HM, Cosgrove BD, Ho AT. The central role of muscle stem cells in regenerative failure with aging. Nat Med 2015; 21: 854-62. Itoh S, Shirabe K, Matsumoto Y et al. Effect of body composition on outcomes after hepatic resection for hepatocellular carcinoma. Ann Surg Oncol 2014; 21: 3063-8. Montano-Loza AJ, Duarte-Rojo A, Meza-Junco J et al. Inclusion of sarcopenia within MELD (MELD-Sarcopenia) and the prediction of mortality in patients with cirrhosis. Clin Transl Gastroenterol 2015; 6: e102. Sadowski CL, Wheeler TT, Wang LH, Sadowski HB. GH regulation of IGF-1 and suppressor of cytokine signaling gene expression in C2C12 skeletal muscle cells. Endocrinology 2001; 142: 3890-900. Chen LK, Liu LK, Woo J et al. Sarcopenia in Asia: Consensus Report of the Asian Working Group for Sarcopenia. J Am Med Dir Assoc 2014; 15: 95-101. Kaido T, Ogawa K, Fujimoto Y et al. Impact of sarcopenia on survival in patients undergoing living donor liver transplantation. Am J Transplant 2013; 13: 1549-56. Harimoto N, Yoshizumi T, Shimokawa M et al. Sarcopenia is a poor prognostic factor following hepatic resection in patients 70 years of age and older with hepatocellular carcinoma. Hepatol Res 2016. DOI:10.1111/hepr.12674 [Epub ahead of print]. Harimoto N, Shirabe K, Yamashita YI et al. Sarcopenia as a predictor of prognosis in patients following hepatectomy for hepatocellular carcinoma. Br J Surg 2013; 100: 1523-30. Scaglione S, Kliethermes S, Cao G et al. The epidemiology of cirrhosis in the United States: a population-based study. J Clin Gastroenterol 2015; 49: 690-6. Moriwaki H, Miwa Y, Tajika M, Kato M, Fukushima H, Shiraki M. Branched-chain amino acids as a protein- and energy-source in liver cirrhosis. Biochem Biophys Res Commun 2004; 313: 405-9. Goldspink G, Williams P, Simpson H. Gene expression in response to muscle stretch. Clin Orthop Relat Res 2002; (403 Suppl): S146-S152. Rosenberg I. Summary comments: epidemiological and methodological problems in determining nutritional status of older persons. Am J Clin Nutr 1989; 50: 1231-33. Janssen I, Heymsfield SB, Wang ZM, Ross R. Skeletal muscle mass and distribution in 468 men and women aged 18-88 yr. J Appl Physiol (1985) 2000; 89: 81-8. Muto Y, Sato S, Watanabe A et al. Effects of oral branched-chain amino acid granules on event-free survival in patients with liver cirrhosis. Clin Gastroenterol Hepatol 2005; 3: 705-13. Sousa-Victor P, Muñoz-Cánoves P. Regenerative decline of stem cells in sarcopenia. Mol Aspects Med 2016; 50: 109-17. Iritani S, Imai K, Takai K et al. Skeletal muscle depletion is an independent prognostic factor for hepatocellular carcinoma. J Gastroenterol 2015; 50: 323-32. Hamaguchi Y, Kaido T, Okumura S et al. Impact of quality as well as quantity of skeletal muscle on outcomes after liver transplantation. Liver Transpl 2014; 20: 1413-9. Montano-Loza AJ. New concepts in liver cirrhosis: clinical significance of sarcopenia in cirrhotic patients. Minerva Gastroenterol Dietol 2013; 59: 173-86. Hsu CY, Lee YH, Hsia CY et al. Performance status in patients with hepatocellular carcinoma: determinants, prognostic impact, and ability to improve the Barcelona Clinic Liver Cancer system. Hepatology 2013; 57: 112-9. Katsanos CS, Kobayashi H, Sheffield-Moore M, Aarsland A, Wolfe RR. A high proportion of leucine is required for optimal stimulation of the rate of muscle protein synthesis by essential amino acids in the elderly. Am J Physiol Endocrinol Metab 2006; 291: E381-E387. Dasarathy S. Consilience in sarcopenia of cirrhosis. J Cachex Sarcopenia Muscle 2012; 3: 225-37. García PS, Cabbabe A, Kambadur R, Nicholas G, Csete M. Brief-reports: elevated myostatin levels in patients with liver disease: a potential contributor to skeletal muscle wasting. Anesth Analg 2010; 111: 707-9. Fielding RA, Vellas B, Evans WJ et al. Sarcopenia: an undiagnosed condition in older adults. Current consensus definition: prevalence, etiology, and consequences. International working group on sarcopenia. J Am Med Dir Assoc 2011; 12: 249-56. Nishikawa H, Yoh K, Enomoto H et al. Factors associated with protein-energy malnutrition in chronic liver disease: analysis using indirect calorimetry. Medicine (Baltimore) 2016; 95: e2442. Shiraki M, Nishiguchi S, Saito M et al. Nutritional status and quality of life in current patients with liver cirrhosis as assessed in 2007-2011. Hepatol Res 2013; 43: 106-12. Sinclair M, Gow PJ, Grossmann M, Angus PW. Review article: sarcopenia in cirrhosis - aetiology, implications and potential therapeutic interventions. Aliment Pharmacol Ther 2016; 43: 765-77. Dodds RM, Roberts HC, Cooper C, Sayer AA. The epidemiology of sarcopenia. J Clin Densitom 2015; 18: 461-466. Grossmann M, Hoermann R, Gani L et al. Low testosterone levels as an independent predictor of mortality in men with chronic liver disease. Clin Endocrinol (Oxf) 2012; 77: 323-8. Durand F, Buyse S, Francoz C et al. Prognostic value of muscle atrophy in cirrhosis using psoas muscle thickness on computed tomography. J Hepatol 2014; 60: 1151-7. Tandon P, Ney M, Irwin I et al. Severe muscle depletion in patients on the liver transplant wait list: its prevalence and independent prognostic value. Liver Transpl 2012; 18: 1209-16. Nishikawa H, Kita R, Kimura T et al. Clinical implication of performance status in patients with hepatocellular carcinoma complicating with cirrhosis. J Cancer 2015; 6: 394-402. Iwasa M, Sugimoto R, Takei Y. Patients with hyponatremic cirrhosis have low-grade cerebral edema and poor quality-of-life. Ann Hepatol 2014; 13: 407-8. Nishikawa H, Osaki Y. Clinical significance of therapy using branched-chain amino acid granules in patients with liver cirrhosis and hepatocellular carcinoma. Hepatol Res 2014; 44: 149-58. Tilg H, Wilmer A, Vogel W et al. Serum levels of cytokines in chronic liver diseases. Gastroenterology 1992; 103: 264-74. Montano-Loza AJ, Meza-Junco J, Prado CM et al. Muscle wasting is associated with mortality in patients with cirrhosis. Clin Gastroenterol Hepatol 2012; 10: 166-73. Lin SY, Chen WY, Lee FY, Huang CJ, Sheu WH. Activation of ubiquitin-proteasome pathway is involved in skeletal muscle wasting in a rat model with biliary cirrhosis: potential role of TNF-alpha. Am J Physiol Endocrinol Metab 2005; 288: E493-E501. Hiraoka A, Aibiki T, Okudaira T et al. Muscle atrophy as pre-sarcopenia in Japanese patients with chronic liver disease: computed tomography is useful for evaluation. J Gastroenterol 2015; 50: 1206-13. Miljkovic N, Lim JY, Miljkovic I, Frontera WR. Aging of skeletal muscle fibers. Ann Rehabil Med 2015; 39: 155-62. Borsheim E, Bui QU, Tissier S et al. Effect of amino acid supplementation on muscle mass, strength and physical function in elderly. Clin Nutr 2008; 27: 189-95. Duan Y, Li F, Li Y, Tang Y et al. The role of leucine and its metabolites in protein and energy metabolism. Amino Acids 2016; 48: 41-51. Qiu J, Thapaliya S, Runkana A et al. Hyperammonemia in cirrhosis induces transcriptional regulation of myostatin by an NF-κB-mediated mechanism. Proc Natl Acad Sci USA 2013; 110: 18162-7. Hamaguchi Y, Kaido T, Okumura S et al. Proposal of new criteria of low skeletal muscle mass using computed tomography imaging in Asia: analysis of 541 healthy adults. Nutrition 2016; in press. doi: 10.1016/j.nut.2016.04.003. Toshikuni N, Arisawa T, Tsutsumi M. Nutrition and exercise in the management of liver cirrhosis. World J Gastroenterol 2014; 20: 7286-97. Hanai T, Shiraki M, Ohnishi S et al. Rapid skeletal muscle wasting predicts worse survival in patients with liver cirrhosis. Hepatol Res 2016; 46: 743-51. Yoshida D, Suzuki T, Shimada H et al. Using two different algorithms to determine the prevalence of sarcopenia. Geriatr Gerontol Int 2014; 14(Suppl. 1): 46-51. Bryant RV, Ooi S, Schultz CG et al. Low muscle mass and sarcopenia: common and predictive of osteopenia in inflammatory bowel disease. Aliment Pharmacol Ther 2015; 41: 895-906. Higashi T, Hayashi H, Taki K et al. Sarcopenia, but not visceral fat amount, is a risk factor of postoperative complications after major hepatectomy. Int J Clin Oncol 2016; 21: 310-9. Fujiwara N, Nakagawa H, Kudo Y et al. Sarcopenia, intramuscular fat deposition, and visceral adiposity independently predict the outcomes of hep 2015; 39 2001; 142 2000; 89 2015; 31 2013; 206 2016; 32 2006; 291 2012; 18 2011; 12 2014; 60 2012; 10 2014; 21 2014; 20 2013; 19 2013; 59 2015; 49 2013; 13 2013; 57 2015; 41 2008; 27 1997; 387 2016; 43 2010; 111 2014; 15 2014; 14 2007; 7 2014; 13 2013; 110 2016; 48 2014; 12 2016; 46 2014; 11 2015; 6 2015; 18 2013; 43 2015; 50 2010; 39 1992; 103 2013; 100 2016; 95 2016; 50 2000; 111 2002 2012; 77 2014; 44 2014; 43 1989; 50 2004; 313 2012; 3 2005; 288 2015; 63 2015; 21 2016; 21 2016 2005; 3 2001; 35 e_1_2_9_31_1 e_1_2_9_52_1 e_1_2_9_50_1 e_1_2_9_35_1 e_1_2_9_56_1 e_1_2_9_12_1 e_1_2_9_33_1 e_1_2_9_54_1 e_1_2_9_14_1 e_1_2_9_39_1 e_1_2_9_16_1 e_1_2_9_37_1 e_1_2_9_58_1 e_1_2_9_18_1 e_1_2_9_41_1 e_1_2_9_64_1 Santilli V (e_1_2_9_10_1) 2014; 11 e_1_2_9_20_1 e_1_2_9_62_1 e_1_2_9_22_1 e_1_2_9_45_1 e_1_2_9_24_1 e_1_2_9_43_1 e_1_2_9_8_1 e_1_2_9_4_1 e_1_2_9_60_1 e_1_2_9_2_1 Dasarathy S (e_1_2_9_6_1) 2016; 32 e_1_2_9_26_1 e_1_2_9_49_1 e_1_2_9_28_1 e_1_2_9_47_1 e_1_2_9_30_1 e_1_2_9_53_1 e_1_2_9_51_1 e_1_2_9_11_1 e_1_2_9_34_1 e_1_2_9_57_1 e_1_2_9_13_1 e_1_2_9_32_1 e_1_2_9_55_1 Mitch WE (e_1_2_9_23_1) 2000; 111 Thompson DD (e_1_2_9_3_1) 2007; 7 e_1_2_9_15_1 e_1_2_9_38_1 e_1_2_9_17_1 e_1_2_9_36_1 e_1_2_9_59_1 e_1_2_9_19_1 e_1_2_9_42_1 e_1_2_9_63_1 e_1_2_9_40_1 e_1_2_9_61_1 e_1_2_9_21_1 e_1_2_9_44_1 e_1_2_9_65_1 e_1_2_9_7_1 e_1_2_9_5_1 Montano‐Loza AJ (e_1_2_9_46_1) 2013; 59 e_1_2_9_9_1 e_1_2_9_25_1 e_1_2_9_27_1 e_1_2_9_48_1 e_1_2_9_29_1 |
| References_xml | – reference: Nishikawa H, Osaki Y. Clinical significance of therapy using branched-chain amino acid granules in patients with liver cirrhosis and hepatocellular carcinoma. Hepatol Res 2014; 44: 149-58. – reference: Montano-Loza AJ, Meza-Junco J, Prado CM et al. Muscle wasting is associated with mortality in patients with cirrhosis. Clin Gastroenterol Hepatol 2012; 10: 166-73. – reference: Hanai T, Shiraki M, Nishimura K et al. Sarcopenia impairs prognosis of patients with liver cirrhosis. Nutrition 2015; 31: 193-9. – reference: Hamaguchi Y, Kaido T, Okumura S et al. Impact of quality as well as quantity of skeletal muscle on outcomes after liver transplantation. Liver Transpl 2014; 20: 1413-9. – reference: Fielding RA, Vellas B, Evans WJ et al. Sarcopenia: an undiagnosed condition in older adults. Current consensus definition: prevalence, etiology, and consequences. International working group on sarcopenia. J Am Med Dir Assoc 2011; 12: 249-56. – reference: Bruix J, Sherman M, Llovet JM et al. Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver. J Hepatol 2001; 35: 421-30. – reference: Muto Y, Sato S, Watanabe A et al. Effects of oral branched-chain amino acid granules on event-free survival in patients with liver cirrhosis. Clin Gastroenterol Hepatol 2005; 3: 705-13. – reference: Higashi T, Hayashi H, Taki K et al. Sarcopenia, but not visceral fat amount, is a risk factor of postoperative complications after major hepatectomy. Int J Clin Oncol 2016; 21: 310-9. – reference: Harimoto N, Yoshizumi T, Shimokawa M et al. Sarcopenia is a poor prognostic factor following hepatic resection in patients 70 years of age and older with hepatocellular carcinoma. Hepatol Res 2016. DOI:10.1111/hepr.12674 [Epub ahead of print]. – reference: Dasarathy S. Cause and management of muscle wasting in chronic liver disease. Curr Opin Gastroenterol 2016; 32: 159-65. – reference: Harimoto N, Shirabe K, Yamashita YI et al. Sarcopenia as a predictor of prognosis in patients following hepatectomy for hepatocellular carcinoma. Br J Surg 2013; 100: 1523-30. – reference: Chen LK, Liu LK, Woo J et al. Sarcopenia in Asia: Consensus Report of the Asian Working Group for Sarcopenia. J Am Med Dir Assoc 2014; 15: 95-101. – reference: Dodds RM, Roberts HC, Cooper C, Sayer AA. The epidemiology of sarcopenia. J Clin Densitom 2015; 18: 461-466. – reference: Itoh S, Shirabe K, Matsumoto Y et al. Effect of body composition on outcomes after hepatic resection for hepatocellular carcinoma. Ann Surg Oncol 2014; 21: 3063-8. – reference: Iwasa M, Sugimoto R, Takei Y. Patients with hyponatremic cirrhosis have low-grade cerebral edema and poor quality-of-life. Ann Hepatol 2014; 13: 407-8. – reference: Hamaguchi Y, Kaido T, Okumura S et al. Proposal of new criteria of low skeletal muscle mass using computed tomography imaging in Asia: analysis of 541 healthy adults. Nutrition 2016; in press. doi: 10.1016/j.nut.2016.04.003. – reference: Borsheim E, Bui QU, Tissier S et al. Effect of amino acid supplementation on muscle mass, strength and physical function in elderly. Clin Nutr 2008; 27: 189-95. – reference: Fujiwara N, Nakagawa H, Kudo Y et al. Sarcopenia, intramuscular fat deposition, and visceral adiposity independently predict the outcomes of hepatocellular carcinoma. J Hepatol 2015; 63: 131-40. – reference: Nishikawa H, Kita R, Kimura T et al. Clinical implication of performance status in patients with hepatocellular carcinoma complicating with cirrhosis. J Cancer 2015; 6: 394-402. – reference: Sinclair M, Gow PJ, Grossmann M, Angus PW. Review article: sarcopenia in cirrhosis - aetiology, implications and potential therapeutic interventions. Aliment Pharmacol Ther 2016; 43: 765-77. – reference: Kawaguchi T, Shiraishi K, Ito T et al. Branched-chain amino acids prevent hepatocarcinogenesis and prolong survival of patients with cirrhosis. Clin Gastroenterol Hepatol 2014; 12: 1012-18. – reference: Toshikuni N, Arisawa T, Tsutsumi M. Nutrition and exercise in the management of liver cirrhosis. World J Gastroenterol 2014; 20: 7286-97. – reference: Hayashi F, Matsumoto Y, Momoki C et al. Physical inactivity and insufficient dietary intake are associated with the frequency of sarcopenia in patients with compensated viral liver cirrhosis. Hepatol Res 2013; 43: 1264-75. – reference: Shiraki M, Nishiguchi S, Saito M et al. Nutritional status and quality of life in current patients with liver cirrhosis as assessed in 2007-2011. Hepatol Res 2013; 43: 106-12. – reference: Bryant RV, Ooi S, Schultz CG et al. Low muscle mass and sarcopenia: common and predictive of osteopenia in inflammatory bowel disease. Aliment Pharmacol Ther 2015; 41: 895-906. – reference: Scaglione S, Kliethermes S, Cao G et al. The epidemiology of cirrhosis in the United States: a population-based study. J Clin Gastroenterol 2015; 49: 690-6. – reference: Hiraoka A, Aibiki T, Okudaira T et al. Muscle atrophy as pre-sarcopenia in Japanese patients with chronic liver disease: computed tomography is useful for evaluation. J Gastroenterol 2015; 50: 1206-13. – reference: Cruz-Jentoft AJ, Landi F, Schneider SM et al. Prevalence of and interventions for sarcopenia in ageing adults: a systematic review. Report of the International Sarcopenia Initiative (EWGSOP and IWGS). Age Ageing 2014; 43: 748-59. – reference: Montano-Loza AJ, Duarte-Rojo A, Meza-Junco J et al. Inclusion of sarcopenia within MELD (MELD-Sarcopenia) and the prediction of mortality in patients with cirrhosis. Clin Transl Gastroenterol 2015; 6: e102. – reference: Mitch WE. Mechanisms accelerating muscle atrophy in catabolic diseases. Trans Am Clin Climatol Assoc 2000; 111: 258-69. – reference: Grossmann M, Hoermann R, Gani L et al. Low testosterone levels as an independent predictor of mortality in men with chronic liver disease. Clin Endocrinol (Oxf) 2012; 77: 323-8. – reference: Santilli V, Bernetti A, Mangone M, Paoloni M. Clinical definition of sarcopenia. Clin Cases Miner Bone Metab 2014; 11: 177-80. – reference: Kaibori M, Ishizaki M, Matsui K et al. Perioperative exercise for chronic liver injury patients with hepatocellular carcinoma undergoing hepatectomy. Am J Surg 2013; 206: 202-9. – reference: Tandon P, Ney M, Irwin I et al. Severe muscle depletion in patients on the liver transplant wait list: its prevalence and independent prognostic value. Liver Transpl 2012; 18: 1209-16. – reference: Goldspink G, Williams P, Simpson H. Gene expression in response to muscle stretch. Clin Orthop Relat Res 2002; (403 Suppl): S146-S152. – reference: Yoshida D, Suzuki T, Shimada H et al. Using two different algorithms to determine the prevalence of sarcopenia. Geriatr Gerontol Int 2014; 14(Suppl. 1): 46-51. – reference: Masuda T, Shirabe K, Ikegami T et al. Sarcopenia is a prognostic factor in living donor liver transplantation. Liver Transpl 2014; 20: 401-7. – reference: Janssen I, Heymsfield SB, Wang ZM, Ross R. Skeletal muscle mass and distribution in 468 men and women aged 18-88 yr. J Appl Physiol (1985) 2000; 89: 81-8. – reference: Cruz-Jentoft AJ, Baeyens JP, Bauer JM et al. Sarcopenia: European consensus on definition and diagnosis. Age Ageing 2010; 39: 412-23. – reference: Blau HM, Cosgrove BD, Ho AT. The central role of muscle stem cells in regenerative failure with aging. Nat Med 2015; 21: 854-62. – reference: Thompson DD. Aging and sarcopenia. J Musculoskelet Neuronal Interact 2007; 7: 344-5. – reference: Montano-Loza AJ. New concepts in liver cirrhosis: clinical significance of sarcopenia in cirrhotic patients. Minerva Gastroenterol Dietol 2013; 59: 173-86. – reference: Nishikawa H, Yoh K, Enomoto H et al. Factors associated with protein-energy malnutrition in chronic liver disease: analysis using indirect calorimetry. Medicine (Baltimore) 2016; 95: e2442. – reference: Lin SY, Chen WY, Lee FY, Huang CJ, Sheu WH. Activation of ubiquitin-proteasome pathway is involved in skeletal muscle wasting in a rat model with biliary cirrhosis: potential role of TNF-alpha. Am J Physiol Endocrinol Metab 2005; 288: E493-E501. – reference: García PS, Cabbabe A, Kambadur R, Nicholas G, Csete M. Brief-reports: elevated myostatin levels in patients with liver disease: a potential contributor to skeletal muscle wasting. Anesth Analg 2010; 111: 707-9. – reference: Iwasa M, Hara N, Terasaka E et al. Evaluation and prognosis of sarcopenia using impedance analysis in patients with liver cirrhosis. Hepatol Res 2014; 44: E316-17. – reference: Kamachi S, Mizuta T, Otsuka T et al. Sarcopenia is a risk factor for the recurrence of hepatocellular carcinoma after curative treatment. Hepatol Res 2016; 46: 201-8. – reference: DiMartini A, Cruz RJ Jr, Dew MA et al. Muscle mass predicts outcomes following liver transplantation. Liver Transpl 2013; 19: 1172-80. – reference: Durand F, Buyse S, Francoz C et al. Prognostic value of muscle atrophy in cirrhosis using psoas muscle thickness on computed tomography. J Hepatol 2014; 60: 1151-7. – reference: Hanai T, Shiraki M, Ohnishi S et al. Rapid skeletal muscle wasting predicts worse survival in patients with liver cirrhosis. Hepatol Res 2016; 46: 743-51. – reference: Sousa-Victor P, Muñoz-Cánoves P. Regenerative decline of stem cells in sarcopenia. Mol Aspects Med 2016; 50: 109-17. – reference: Rosenberg I. Summary comments: epidemiological and methodological problems in determining nutritional status of older persons. Am J Clin Nutr 1989; 50: 1231-33. – reference: Qiu J, Thapaliya S, Runkana A et al. Hyperammonemia in cirrhosis induces transcriptional regulation of myostatin by an NF-κB-mediated mechanism. Proc Natl Acad Sci USA 2013; 110: 18162-7. – reference: Kaido T, Ogawa K, Fujimoto Y et al. Impact of sarcopenia on survival in patients undergoing living donor liver transplantation. Am J Transplant 2013; 13: 1549-56. – reference: Iritani S, Imai K, Takai K et al. Skeletal muscle depletion is an independent prognostic factor for hepatocellular carcinoma. J Gastroenterol 2015; 50: 323-32. – reference: Sadowski CL, Wheeler TT, Wang LH, Sadowski HB. GH regulation of IGF-1 and suppressor of cytokine signaling gene expression in C2C12 skeletal muscle cells. Endocrinology 2001; 142: 3890-900. – reference: Dasarathy S. Consilience in sarcopenia of cirrhosis. J Cachex Sarcopenia Muscle 2012; 3: 225-37. – reference: Tilg H, Wilmer A, Vogel W et al. Serum levels of cytokines in chronic liver diseases. Gastroenterology 1992; 103: 264-74. – reference: Duan Y, Li F, Li Y, Tang Y et al. The role of leucine and its metabolites in protein and energy metabolism. Amino Acids 2016; 48: 41-51. – reference: Hsu CY, Lee YH, Hsia CY et al. Performance status in patients with hepatocellular carcinoma: determinants, prognostic impact, and ability to improve the Barcelona Clinic Liver Cancer system. Hepatology 2013; 57: 112-9. – reference: Katsanos CS, Kobayashi H, Sheffield-Moore M, Aarsland A, Wolfe RR. A high proportion of leucine is required for optimal stimulation of the rate of muscle protein synthesis by essential amino acids in the elderly. Am J Physiol Endocrinol Metab 2006; 291: E381-E387. – reference: Miljkovic N, Lim JY, Miljkovic I, Frontera WR. Aging of skeletal muscle fibers. Ann Rehabil Med 2015; 39: 155-62. – reference: McPherron AC, Lawler AM, Lee SJ. Regulation of skeletal muscle mass in mice by a new TGF-beta superfamily member. Nature 1997; 387: 83-90. – reference: Moriwaki H, Miwa Y, Tajika M, Kato M, Fukushima H, Shiraki M. Branched-chain amino acids as a protein- and energy-source in liver cirrhosis. Biochem Biophys Res Commun 2004; 313: 405-9. – volume: 7 start-page: 344 year: 2007 end-page: 5 article-title: Aging and sarcopenia publication-title: J Musculoskelet Neuronal Interact – volume: 50 start-page: 1206 year: 2015 end-page: 13 article-title: Muscle atrophy as pre‐sarcopenia in Japanese patients with chronic liver disease: computed tomography is useful for evaluation publication-title: J Gastroenterol – volume: 43 start-page: 106 year: 2013 end-page: 12 article-title: Nutritional status and quality of life in current patients with liver cirrhosis as assessed in 2007–2011 publication-title: Hepatol Res – volume: 46 start-page: 743 year: 2016 end-page: 51 article-title: Rapid skeletal muscle wasting predicts worse survival in patients with liver cirrhosis publication-title: Hepatol Res – volume: 39 start-page: 155 year: 2015 end-page: 62 article-title: Aging of skeletal muscle fibers publication-title: Ann Rehabil Med – volume: 12 start-page: 249 year: 2011 end-page: 56 article-title: Sarcopenia: an undiagnosed condition in older adults. Current consensus definition: prevalence, etiology, and consequences. International working group on sarcopenia publication-title: J Am Med Dir Assoc – volume: 27 start-page: 189 year: 2008 end-page: 95 article-title: Effect of amino acid supplementation on muscle mass, strength and physical function in elderly publication-title: Clin Nutr – volume: 18 start-page: 461 year: 2015 end-page: 466 article-title: The epidemiology of sarcopenia publication-title: J Clin Densitom – volume: 111 start-page: 707 year: 2010 end-page: 9 article-title: Brief‐reports: elevated myostatin levels in patients with liver disease: a potential contributor to skeletal muscle wasting publication-title: Anesth Analg – year: 2016 article-title: Proposal of new criteria of low skeletal muscle mass using computed tomography imaging in Asia: analysis of 541 healthy adults publication-title: Nutrition – volume: 313 start-page: 405 year: 2004 end-page: 9 article-title: Branched‐chain amino acids as a protein‐ and energy‐source in liver cirrhosis publication-title: Biochem Biophys Res Commun – volume: 387 start-page: 83 year: 1997 end-page: 90 article-title: Regulation of skeletal muscle mass in mice by a new TGF‐beta superfamily member publication-title: Nature – volume: 20 start-page: 1413 year: 2014 end-page: 9 article-title: Impact of quality as well as quantity of skeletal muscle on outcomes after liver transplantation publication-title: Liver Transpl – volume: 32 start-page: 159 year: 2016 end-page: 65 article-title: Cause and management of muscle wasting in chronic liver disease publication-title: Curr Opin Gastroenterol – volume: 111 start-page: 258 year: 2000 end-page: 69 article-title: Mechanisms accelerating muscle atrophy in catabolic diseases publication-title: Trans Am Clin Climatol Assoc – volume: 291 start-page: E381 year: 2006 end-page: E387 article-title: A high proportion of leucine is required for optimal stimulation of the rate of muscle protein synthesis by essential amino acids in the elderly publication-title: Am J Physiol Endocrinol Metab – volume: 13 start-page: 1549 year: 2013 end-page: 56 article-title: Impact of sarcopenia on survival in patients undergoing living donor liver transplantation publication-title: Am J Transplant – start-page: S146 issue: 403 Suppl year: 2002 end-page: S152 article-title: Gene expression in response to muscle stretch publication-title: Clin Orthop Relat Res – volume: 31 start-page: 193 year: 2015 end-page: 9 article-title: Sarcopenia impairs prognosis of patients with liver cirrhosis publication-title: Nutrition – volume: 6 start-page: 394 year: 2015 end-page: 402 article-title: Clinical implication of performance status in patients with hepatocellular carcinoma complicating with cirrhosis publication-title: J Cancer – volume: 35 start-page: 421 year: 2001 end-page: 30 article-title: Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona‐2000 EASL conference. European Association for the Study of the Liver publication-title: J Hepatol – volume: 19 start-page: 1172 year: 2013 end-page: 80 article-title: Muscle mass predicts outcomes following liver transplantation publication-title: Liver Transpl – volume: 60 start-page: 1151 year: 2014 end-page: 7 article-title: Prognostic value of muscle atrophy in cirrhosis using psoas muscle thickness on computed tomography publication-title: J Hepatol – volume: 18 start-page: 1209 year: 2012 end-page: 16 article-title: Severe muscle depletion in patients on the liver transplant wait list: its prevalence and independent prognostic value publication-title: Liver Transpl – volume: 50 start-page: 109 year: 2016 end-page: 17 article-title: Regenerative decline of stem cells in sarcopenia publication-title: Mol Aspects Med – volume: 206 start-page: 202 year: 2013 end-page: 9 article-title: Perioperative exercise for chronic liver injury patients with hepatocellular carcinoma undergoing hepatectomy publication-title: Am J Surg – volume: 39 start-page: 412 year: 2010 end-page: 23 article-title: Sarcopenia: European consensus on definition and diagnosis publication-title: Age Ageing – volume: 57 start-page: 112 year: 2013 end-page: 9 article-title: Performance status in patients with hepatocellular carcinoma: determinants, prognostic impact, and ability to improve the Barcelona Clinic Liver Cancer system publication-title: Hepatology – volume: 10 start-page: 166 year: 2012 end-page: 73 article-title: Muscle wasting is associated with mortality in patients with cirrhosis publication-title: Clin Gastroenterol Hepatol – volume: 20 start-page: 7286 year: 2014 end-page: 97 article-title: Nutrition and exercise in the management of liver cirrhosis publication-title: World J Gastroenterol – volume: 13 start-page: 407 year: 2014 end-page: 8 article-title: Patients with hyponatremic cirrhosis have low‐grade cerebral edema and poor quality‐of‐life publication-title: Ann Hepatol – volume: 43 start-page: 748 year: 2014 end-page: 59 article-title: Prevalence of and interventions for sarcopenia in ageing adults: a systematic review. Report of the International Sarcopenia Initiative (EWGSOP and IWGS) publication-title: Age Ageing – volume: 43 start-page: 765 year: 2016 end-page: 77 article-title: Review article: sarcopenia in cirrhosis – aetiology, implications and potential therapeutic interventions publication-title: Aliment Pharmacol Ther – volume: 21 start-page: 310 year: 2016 end-page: 9 article-title: Sarcopenia, but not visceral fat amount, is a risk factor of postoperative complications after major hepatectomy publication-title: Int J Clin Oncol – volume: 50 start-page: 1231 year: 1989 end-page: 33 article-title: Summary comments: epidemiological and methodological problems in determining nutritional status of older persons publication-title: Am J Clin Nutr – volume: 49 start-page: 690 year: 2015 end-page: 6 article-title: The epidemiology of cirrhosis in the United States: a population‐based study publication-title: J Clin Gastroenterol – volume: 46 start-page: 201 year: 2016 end-page: 8 article-title: Sarcopenia is a risk factor for the recurrence of hepatocellular carcinoma after curative treatment publication-title: Hepatol Res – volume: 110 start-page: 18162 year: 2013 end-page: 7 article-title: Hyperammonemia in cirrhosis induces transcriptional regulation of myostatin by an NF‐κB‐mediated mechanism publication-title: Proc Natl Acad Sci USA – volume: 3 start-page: 705 year: 2005 end-page: 13 article-title: Effects of oral branched‐chain amino acid granules on event‐free survival in patients with liver cirrhosis publication-title: Clin Gastroenterol Hepatol – volume: 15 start-page: 95 year: 2014 end-page: 101 article-title: Sarcopenia in Asia: Consensus Report of the Asian Working Group for Sarcopenia publication-title: J Am Med Dir Assoc – volume: 43 start-page: 1264 year: 2013 end-page: 75 article-title: Physical inactivity and insufficient dietary intake are associated with the frequency of sarcopenia in patients with compensated viral liver cirrhosis publication-title: Hepatol Res – volume: 20 start-page: 401 year: 2014 end-page: 7 article-title: Sarcopenia is a prognostic factor in living donor liver transplantation publication-title: Liver Transpl – volume: 11 start-page: 177 year: 2014 end-page: 80 article-title: Clinical definition of sarcopenia publication-title: Clin Cases Miner Bone Metab – volume: 59 start-page: 173 year: 2013 end-page: 86 article-title: New concepts in liver cirrhosis: clinical significance of sarcopenia in cirrhotic patients publication-title: Minerva Gastroenterol Dietol – volume: 21 start-page: 3063 year: 2014 end-page: 8 article-title: Effect of body composition on outcomes after hepatic resection for hepatocellular carcinoma publication-title: Ann Surg Oncol – volume: 44 start-page: E316 year: 2014 end-page: 17 article-title: Evaluation and prognosis of sarcopenia using impedance analysis in patients with liver cirrhosis publication-title: Hepatol Res – volume: 100 start-page: 1523 year: 2013 end-page: 30 article-title: Sarcopenia as a predictor of prognosis in patients following hepatectomy for hepatocellular carcinoma publication-title: Br J Surg – volume: 21 start-page: 854 year: 2015 end-page: 62 article-title: The central role of muscle stem cells in regenerative failure with aging publication-title: Nat Med – volume: 44 start-page: 149 year: 2014 end-page: 58 article-title: Clinical significance of therapy using branched‐chain amino acid granules in patients with liver cirrhosis and hepatocellular carcinoma publication-title: Hepatol Res – volume: 142 start-page: 3890 year: 2001 end-page: 900 article-title: GH regulation of IGF‐1 and suppressor of cytokine signaling gene expression in C2C12 skeletal muscle cells publication-title: Endocrinology – volume: 95 start-page: e2442 year: 2016 article-title: Factors associated with protein‐energy malnutrition in chronic liver disease: analysis using indirect calorimetry publication-title: Medicine (Baltimore) – volume: 103 start-page: 264 year: 1992 end-page: 74 article-title: Serum levels of cytokines in chronic liver diseases publication-title: Gastroenterology – volume: 6 start-page: e102 year: 2015 article-title: Inclusion of sarcopenia within MELD (MELD‐Sarcopenia) and the prediction of mortality in patients with cirrhosis publication-title: Clin Transl Gastroenterol – volume: 89 start-page: 81 year: 2000 end-page: 8 article-title: Skeletal muscle mass and distribution in 468 men and women aged 18–88 yr publication-title: J Appl Physiol (1985) – volume: 48 start-page: 41 year: 2016 end-page: 51 article-title: The role of leucine and its metabolites in protein and energy metabolism publication-title: Amino Acids – year: 2016 article-title: Sarcopenia is a poor prognostic factor following hepatic resection in patients 70 years of age and older with hepatocellular carcinoma publication-title: Hepatol Res – volume: 41 start-page: 895 year: 2015 end-page: 906 article-title: Low muscle mass and sarcopenia: common and predictive of osteopenia in inflammatory bowel disease publication-title: Aliment Pharmacol Ther – volume: 3 start-page: 225 year: 2012 end-page: 37 article-title: Consilience in sarcopenia of cirrhosis publication-title: J Cachex Sarcopenia Muscle – volume: 50 start-page: 323 year: 2015 end-page: 32 article-title: Skeletal muscle depletion is an independent prognostic factor for hepatocellular carcinoma publication-title: J Gastroenterol – volume: 288 start-page: E493 year: 2005 end-page: E501 article-title: Activation of ubiquitin‐proteasome pathway is involved in skeletal muscle wasting in a rat model with biliary cirrhosis: potential role of TNF‐alpha publication-title: Am J Physiol Endocrinol Metab – volume: 63 start-page: 131 year: 2015 end-page: 40 article-title: Sarcopenia, intramuscular fat deposition, and visceral adiposity independently predict the outcomes of hepatocellular carcinoma publication-title: J Hepatol – volume: 14 start-page: 46 issue: Suppl. 1 year: 2014 end-page: 51 article-title: Using two different algorithms to determine the prevalence of sarcopenia publication-title: Geriatr Gerontol Int – volume: 77 start-page: 323 year: 2012 end-page: 8 article-title: Low testosterone levels as an independent predictor of mortality in men with chronic liver disease publication-title: Clin Endocrinol (Oxf) – volume: 12 start-page: 1012 year: 2014 end-page: 18 article-title: Branched‐chain amino acids prevent hepatocarcinogenesis and prolong survival of patients with cirrhosis publication-title: Clin Gastroenterol Hepatol – ident: e_1_2_9_22_1 doi: 10.1007/s00726-015-2067-1 – volume: 32 start-page: 159 year: 2016 ident: e_1_2_9_6_1 article-title: Cause and management of muscle wasting in chronic liver disease publication-title: Curr Opin Gastroenterol – ident: e_1_2_9_45_1 doi: 10.1111/hepr.12085 – ident: e_1_2_9_18_1 doi: 10.1210/endo.142.9.8365 – ident: e_1_2_9_43_1 doi: 10.1002/lt.23970 – ident: e_1_2_9_8_1 doi: 10.1111/hepr.12616 – ident: e_1_2_9_5_1 doi: 10.1038/nm.3918 – volume: 11 start-page: 177 year: 2014 ident: e_1_2_9_10_1 article-title: Clinical definition of sarcopenia publication-title: Clin Cases Miner Bone Metab – ident: e_1_2_9_20_1 doi: 10.1152/ajpendo.00488.2005 – ident: e_1_2_9_32_1 doi: 10.5535/arm.2015.39.2.155 – ident: e_1_2_9_39_1 doi: 10.1002/lt.23811 – ident: e_1_2_9_31_1 doi: 10.1016/j.jocd.2015.04.012 – ident: e_1_2_9_41_1 doi: 10.1111/ajt.12221 – ident: e_1_2_9_36_1 doi: 10.1007/s10147-015-0898-0 – ident: e_1_2_9_58_1 doi: 10.1002/lt.23495 – ident: e_1_2_9_33_1 doi: 10.1097/MCG.0000000000000208 – ident: e_1_2_9_48_1 doi: 10.1111/hepr.12004 – ident: e_1_2_9_24_1 doi: 10.1111/j.1365-2265.2012.04347.x – ident: e_1_2_9_40_1 doi: 10.1002/bjs.9258 – ident: e_1_2_9_63_1 doi: 10.1111/ggi.12210 – ident: e_1_2_9_59_1 doi: 10.1038/ctg.2015.31 – volume: 111 start-page: 258 year: 2000 ident: e_1_2_9_23_1 article-title: Mechanisms accelerating muscle atrophy in catabolic diseases publication-title: Trans Am Clin Climatol Assoc – ident: e_1_2_9_62_1 doi: 10.1016/j.jamda.2013.11.025 – ident: e_1_2_9_25_1 doi: 10.1038/387083a0 – ident: e_1_2_9_16_1 doi: 10.1016/S1542-3565(05)00017-0 – ident: e_1_2_9_7_1 doi: 10.1111/apt.13549 – ident: e_1_2_9_4_1 doi: 10.1016/j.mam.2016.02.002 – ident: e_1_2_9_21_1 doi: 10.1016/j.clnu.2008.01.001 – ident: e_1_2_9_30_1 doi: 10.1152/ajpendo.00186.2004 – volume: 59 start-page: 173 year: 2013 ident: e_1_2_9_46_1 article-title: New concepts in liver cirrhosis: clinical significance of sarcopenia in cirrhotic patients publication-title: Minerva Gastroenterol Dietol – ident: e_1_2_9_61_1 doi: 10.1016/j.jamda.2011.01.003 – ident: e_1_2_9_65_1 doi: 10.1016/j.nut.2016.04.003 – ident: e_1_2_9_11_1 doi: 10.1016/j.bbrc.2003.07.016 – ident: e_1_2_9_38_1 doi: 10.1007/s00535-014-0964-9 – ident: e_1_2_9_14_1 doi: 10.1152/jappl.2000.89.1.81 – ident: e_1_2_9_15_1 doi: 10.1016/j.nut.2014.07.005 – ident: e_1_2_9_64_1 doi: 10.1111/hepr.12217 – volume: 7 start-page: 344 year: 2007 ident: e_1_2_9_3_1 article-title: Aging and sarcopenia publication-title: J Musculoskelet Neuronal Interact – ident: e_1_2_9_12_1 doi: 10.1097/MD.0000000000002442 – ident: e_1_2_9_19_1 doi: 10.1097/00003086-200210001-00017 – ident: e_1_2_9_35_1 doi: 10.1111/hepr.12674 – ident: e_1_2_9_50_1 doi: 10.7150/jca.11212 – ident: e_1_2_9_28_1 doi: 10.1007/s13539-012-0069-3 – ident: e_1_2_9_52_1 doi: 10.1016/j.amjsurg.2012.07.035 – ident: e_1_2_9_17_1 doi: 10.1016/j.cgh.2013.08.050 – ident: e_1_2_9_13_1 doi: 10.1111/hepr.12194 – ident: e_1_2_9_60_1 doi: 10.1093/ageing/afq034 – ident: e_1_2_9_51_1 doi: 10.1016/S0168-8278(01)00130-1 – ident: e_1_2_9_34_1 doi: 10.1111/apt.13156 – ident: e_1_2_9_49_1 doi: 10.1002/hep.25950 – ident: e_1_2_9_53_1 doi: 10.3748/wjg.v20.i23.7286 – ident: e_1_2_9_27_1 doi: 10.1073/pnas.1317049110 – ident: e_1_2_9_55_1 doi: 10.1007/s00535-015-1068-x – ident: e_1_2_9_54_1 doi: 10.1016/j.jhep.2014.02.026 – ident: e_1_2_9_9_1 doi: 10.1093/ageing/afu115 – ident: e_1_2_9_37_1 doi: 10.1111/hepr.12562 – ident: e_1_2_9_47_1 doi: 10.1016/S1665-2681(19)30874-9 – ident: e_1_2_9_42_1 doi: 10.1016/j.jhep.2015.02.031 – ident: e_1_2_9_2_1 doi: 10.1093/ajcn/50.5.1231 – ident: e_1_2_9_26_1 doi: 10.1213/ANE.0b013e3181eac1c9 – ident: e_1_2_9_56_1 doi: 10.1016/j.cgh.2011.08.028 – ident: e_1_2_9_44_1 doi: 10.1245/s10434-014-3686-6 – ident: e_1_2_9_57_1 doi: 10.1002/lt.23724 – ident: e_1_2_9_29_1 doi: 10.1016/0016-5085(92)91122-K |
| SSID | ssj0017024 |
| Score | 2.609191 |
| Snippet | Sarcopenia is defined by muscle loss and muscle dysfunction. Sarcopenia is classified into primary and secondary types, based on the cause. Primary sarcopenia... |
| SourceID | proquest pubmed crossref wiley istex |
| SourceType | Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | 951 |
| SubjectTerms | assessment criteria liver disease mechanism prognosis sarcopenia |
| Title | Japan Society of Hepatology guidelines for sarcopenia in liver disease (1st edition): Recommendation from the working group for creation of sarcopenia assessment criteria |
| URI | https://api.istex.fr/ark:/67375/WNG-TV40MNHV-3/fulltext.pdf https://onlinelibrary.wiley.com/doi/abs/10.1111%2Fhepr.12774 https://www.ncbi.nlm.nih.gov/pubmed/27481650 https://www.proquest.com/docview/1816864191 |
| Volume | 46 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3ra9UwFD-MDcQvOp-r0xFRxAm9NG2StuKXTXctg3uRsc19kZK2iV629Y77wMef5F_pOenDTYag3wI9TdL0nJzfSc4D4LlNdaW0SnwdVMYXicSWUcpH29mWMkyL1FI08missiOxfyJPVuBNFwvT5IfoD9xIMtx-TQKui_klIf9iLmYDHiJ8wQ2YnLUIER30uaN4HLQVbRPlq0ioNjcpufH8fvWKNlqjhf12HdS8ilyd6hnehk_dpBuPk9PBclEMyh9_5HP8369ah1stJmU7DRPdgRVT34Ubo_bW_R783EeNWrPWwZNNLctQibnCt9_Z5yUlyiLneYb4l81RcKgi10SzSc3OyOuDtZdA7CWfLxj2Sryw_ZqR5Xt-btqqTowCXRjCUfa1Ob9nLuDEddohWxr60gC6zyqKFBRKPdH34Wi4d_g289saD34pZCz8NCllEKVaaMl1qKW0hQwro6IYoWClYmFRy_IKbQATJlVShAlXpjIFsp5C5GaiB7BaT2uzAUxrhViXSKQQlicJt6WtrNQIMmOeag-2u3-dl20CdKrDcZZ3hhAtfu4W34NnPe1Fk_bjWqoXjmV6Ej07JUe5WOYfx-_zw2MRjMbZcR558LTjqRzFl-5kdG2my3nOqe6JEmg1e_CwYba-tzAW-FQGHrxyLPOXmeTZ3ocD13r0L8SbcBMBoGp85h7D6mK2NE8QZC2KLVjb2X23O9xyQvUL008m_w |
| linkProvider | Wiley-Blackwell |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V3bbtQwEB2VVgJeuFPC1YiLKFJWcdZ2EiQeEG1JL7tC1bb0zXUSB1Zts9VeVMonIfErfBMzudGiComHPvAWaUeO156xj-OZcwCe55HJlFGha7zMuiKU-GSVcvHsnKfSj5Iop2rkXl_F22J9V-7OwY-mFqbih2g_uFFklOs1BTh9kD4V5V_s0bjDfcQvdU7lhj05xhPb5O3aMk7vC99fXRm8j91aVMBNhQyEG4Wp9LqREUZy4xsp80T6mVVdUqnPVCByXNZ5hqDT-mEWJn7Ilc1sgv9VIVSwXWz3EiyQhDhR9S9vtWxVPPBqDd1QuaorVM2GSolDv_t6Zv9boKn8eh64PYuVy81u9Tr8bIapynHZ78ymSSf99geD5H8zjjfgWg272bsqTm7CnC1uweVenVhwG76vI2goWJ3DykY5i3GfLrV9T9jnGXGBUX0AQ4jPJth7Eh0bGjYs2AEltrD6nou94pMpw1bJ3ZfeMDrcHx7aWriKUS0PQ8TNjqsrClbW1JSNNuCdXn3qBaYlTkULqhYfmjuwfSEjdRfmi1Fh7wEzRiGcJxMpRM7DkOdpnuXSII4OeGQcWGqcS6c1xztJjRzo5qxHk63LyXbgWWt7VDGbnGv1svTR1sSM9ykXMJD6U_-DHuwIr9ePd3TXgaeNE2tcoejayRR2NJtoTtIuSvCIO7BYeXfbmh8I_FV6DrwuffQvPdHxyset8un-vxg_gSvxoLepN9f6Gw_gKuJdVaUIPoT56XhmHyGmnCaPy0hmsHfRLv8LFiKCWA |
| linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1Zb9QwEB6VVqp44T6W04hDFCmrOLGdBIkHxHbZtuyqqtrSt-Akdrtqm13toVJ-EuKv8J-YyUWLKiQe-sBbpIzGjj1jf45n5gN4YSOdKa1CR7uZcUQo8cko5eDZ2abSi5LIUjZyf6B6O2J9T-4twI86F6asD9H8cCPPKNZrcvBxZs84-YEZT9rcQ_hShVRumNMTPLBN3611cHZfel53dftDz6k4BZxUyEA4UZhK14-00JJrT0tpE-llRvlEUp-pQFhc1XmGmNN4YRYmXsiVyUyCn6oQKRgf9V6BJaHciIgiOltNsSoeuBWFbqgc5QtVFUOluKHffT23_S3RTH69CNueh8rFXte9Dj_rUSpDXA7b81nSTr_9UUDyfxnGG3CtAt3sfeklN2HB5LdguV-FFdyG7-sIGXJWRbCykWU93KULZt9Ttj-nSmCUHcAQ4LMp9p4ox4aaDXN2RGEtrLrlYq_5dMZQKxn7yltGR_vjY1PRVjHK5GGIt9lJeUHBioyaQmkN3anpMw3opmwqSlCu-FDfgZ1LGam7sJiPcnMfmNYKwTyJSCEsD0NuU5tZqRFFBzzSLVipbStOqwrvRDRyFNcnPZrsuJjsFjxvZMdlXZMLpV4VJtqI6MkhRQIGMv48-Bhv7wq3P-jtxn4LntU2HOP6RJdOOjej-TTmROyiBI94C-6Vxt1o8wKBb6XbgjeFif6lJ3FvdXOreHrwL8JPYXmz040_rQ02HsJVBLuqjA98BIuzydw8RkA5S54Ufszgy2Vb_C8BXIEH |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Japan+Society+of+Hepatology+guidelines+for+sarcopenia+in+liver+disease+%281st+edition%29%3A+Recommendation+from+the+working+group+for+creation+of+sarcopenia+assessment+criteria&rft.jtitle=Hepatology+research&rft.au=Nishikawa%2C+Hiroki&rft.au=Shiraki%2C+Makoto&rft.au=Hiramatsu%2C+Akira&rft.au=Moriya%2C+Kyoji&rft.date=2016-09-01&rft.pub=Blackwell+Publishing+Ltd&rft.issn=1386-6346&rft.eissn=1872-034X&rft.volume=46&rft.issue=10&rft.spage=951&rft.epage=963&rft_id=info:doi/10.1111%2Fhepr.12774&rft.externalDBID=n%2Fa&rft.externalDocID=ark_67375_WNG_TV40MNHV_3 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1386-6346&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1386-6346&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1386-6346&client=summon |